- Previous Close
0.062 - Open
0.058 - Bid 0.050 x --
- Ask 0.051 x --
- Day's Range
0.049 - 0.062 - 52 Week Range
0.032 - 0.115 - Volume
16,192,000 - Avg. Volume
3,287,080 - Market Cap (intraday)
42.103M - Beta (5Y Monthly) 0.74
- PE Ratio (TTM)
-- - EPS (TTM)
-3.100 - Earnings Date Feb 28, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
China Health Technology Group Holding Company Limited, an investment holding company, engages in the forestry management business in the People's Republic of China. It operates through Forestry Business, Ginseng Business, and Horny Goat Weed Business segments. The Forestry Business segment engages in the plantation, logging, and sale of timber related products. The Ginseng Business segment is involved in the ginseng plantation and trading of related products. The Horny Goat Weed Business segment engages in the horny goat weed plantation and trading of related products. The company was formerly known as China Bozza Development Holdings Limited and changed its name to China Health Technology Group Holding Company Limited in December 2023. China Health Technology Group Holding Company Limited was incorporated in 2009 and is headquartered in Shenzhen, China.
www.01069.com.cn27
Full Time Employees
June 30
Fiscal Year Ends
Sector
Industry
Recent News: 1069.HK
View MorePerformance Overview: 1069.HK
Trailing total returns as of 4/9/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 1069.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 1069.HK
View MoreValuation Measures
Market Cap
53.27M
Enterprise Value
173.42M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.01
Price/Book (mrq)
2.01
Enterprise Value/Revenue
2.72
Enterprise Value/EBITDA
19.92
Financial Highlights
Profitability and Income Statement
Profit Margin
5.98%
Return on Assets (ttm)
-8.45%
Return on Equity (ttm)
17.13%
Revenue (ttm)
59.7M
Net Income Avi to Common (ttm)
3.57M
Diluted EPS (ttm)
-3.100
Balance Sheet and Cash Flow
Total Cash (mrq)
2.68M
Total Debt/Equity (mrq)
463.37%
Levered Free Cash Flow (ttm)
-31.68M